$19.84
-0.08 (-0.40%)
Open$20.01
Previous Close$19.92
Day High$20.33
Day Low$19.65
52W High$21.96
52W Low$6.92
Volume—
Avg Volume981.5K
Market Cap1.48B
P/E Ratio—
EPS$-2.30
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+24.8% upside
Current
$19.84
$19.84
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 126.42M | 138.36M | 205.11M |
| Net Income | -92,542,456 | -91,154,876 | -12,900,416 |
| Profit Margin | -73.2% | -69.5% | -6.3% |
| EBITDA | -177,349,373 | -184,395,211 | -15,864,221 |
| Free Cash Flow | — | — | -6,278,593 |
| Rev Growth | -8.6% | -8.6% | +24.6% |
| Debt/Equity | 0.19 | 0.19 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |